1,721,031 research outputs found
DS_10.1177_0272989X18797948 – Supplemental material for Value of Information Choices That Influence Estimates: A Systematic Review of Prevailing Considerations
No full textSupplemental material, DS_10.1177_0272989X18797948 for Value of Information Choices That Influence Estimates: A Systematic Review of Prevailing Considerations by Hendrik Koffijberg, Claire Rothery, Kalipso Chalkidou and Janneke Grutters in Medical Decision Making</p
Comparative Effectiveness Review Within the U.K.'s National Institute for Health and Clinical Excellence
Full text linkExamines lessons from the National Institute for Health and Clinical Excellence's use of comparative effectiveness reviews and decision-making process on evidence-based standards, uptake of medical innovations, and investment for maximum health benefit
DEBATE Open Access Sharing the British National Health Service around
No full textAs the UK reiterates its commitment to protecting and growing its development aid budget amidst an adverse economic environment for the UK and Europe, we discuss the potential to use the country’s National Health Service (NHS) model as a vehicle for promoting the country’s economic as well as global health diplomacy and development priorities, through a coordinated cross-government plan of action. With the country’s Prime Minister serving as a co-chair of the UN post-2015 development agenda panel, a this is a unique opportunity for the UK to put forward its health system architecture as a highly applicable and well-tested model for providing access to efficient and cost-effective care, with minimal financial hardship. Arguably, such a model tailored to the needs of specific countries could consequently lead to commercial opportunities for UK plc. in areas such as consulting, training, education and healthcare products. Finally, this approach would be consistent with the current thinking on the evolving role of UK aid, especially in the case of emerging powers such as India, where the focus has shifted from aid to investment in technical assistance and cooperation as a means of boosting bilateral business and trade
9. Deliberative Processes in Decisions about Best Buys, Wasted Buys, and Contestable Buys
No full textIs competition bad for our health(care)? We simply don't know
No full textIn The Lancet Oncology, Ajay Aggarwal and colleagues1 apply innovative analytics to study the movement patterns of almost 20 000 patients accessing prostate cancer surgery across the National Health Service (NHS) in England between 2010 and 2014. They find that, in the presence of pressures to centralise surgical services and intense competition, and in the absence of any publicly accessible measure of service quality to allow comparisons, those providers who invest in high tech, in this case robotic, surgery equipment, fare better than those who don't in attracting patients and growing their business. In fact, those who don't, risk closure. One in four of the country's 65 radical prostatectomy centres closed between 2010 and 2017, with a trebling of the number of robotic centres over the same period. None of the 16 NHS centres that closed had invested in robotic equipment. Nor had any of the centres that closed done so because of explicit evidence of poorer quality. Moreover, in a previous analysis of referral patterns for specialised prostate cancer surgery,2 the same authors showed that patients who travel longer distances, bypassing their local centres, tend to be younger, less ill, and of higher socioeconomic background than those who do not.Full Tex
Using Comparative Effectiveness Research to Inform Policy and Practice in the UK NHS: Past, Present and Future
No full textHealth systems that have fixed budgets and a coherent organizational structure generally have found it valuable to have a dedicated primary research capacity to answer decision-oriented value-for-money questions of particular importance to the system. The UK NHS is one example of such a system. Here, we review the historical evolution of building comparative effectiveness research (CER) capacity in the NHS, describe the current situation, with a focus on how this research is used to inform decisions, and discuss present and emerging challenges. We draw some possible lessons for the US, which is currently considering using CER to inform healthcare policy and practice decisions.cost-effectiveness, decision-making, formularies, research-and-development, treatment-outcome
- …
